BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36989893)

  • 1. IKBIP might be a potential prognostic biomarker for glioblastoma multiforme.
    Chen H; Liang B; Luo X; Zhang W; Song X; Lan H; Yue Q; Xie J; Zhang M
    Int Immunopharmacol; 2023 May; 118():110030. PubMed ID: 36989893
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yang Y; Wang J; Xu S; Lv W; Shi F; Shan A
    Transl Neurosci; 2021 Jan; 12(1):9-19. PubMed ID: 33552590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4.
    Li K; Huang G; Wang Z; Yang R; Zhang W; Ni B; Guan J; Yi G; Li Z; Zhu Q; Peng Q; Yang L; Qi L; Liu Y
    Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166571. PubMed ID: 36244542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease.
    Zhao S; Chi H; Yang Q; Chen S; Wu C; Lai G; Xu K; Su K; Luo H; Peng G; Xia Z; Cheng C; Lu P
    Front Immunol; 2023; 14():1090040. PubMed ID: 36825022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of Novel Methylation-Driven Gene Model and Investigation of PARVB Function in Glioblastoma.
    Yu W; Wu P; Wang F; Miao L; Han B; Jiang Z
    Front Oncol; 2021; 11():705547. PubMed ID: 34568031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients.
    Cheng L; Yuan M; Li S; Lian Z; Chen J; Lin W; Zhang J; Zhong S
    Ann Transl Med; 2021 Jun; 9(11):925. PubMed ID: 34350240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
    Wang D; Jiang Y; Wang T; Wang Z; Zou F
    BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
    Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
    Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of IKBIP in papillary renal cell carcinoma.
    Zhang H; Tang R; Wen X; Cai J; Huang J; Luo L; Yang Z
    BMC Urol; 2023 Jul; 23(1):121. PubMed ID: 37454079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
    Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
    Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
    Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I kappa B kinase interacting protein as a promising biomarker in pan-cancer: A multi-omics analysis.
    Bi C; Wang Z; Xiao Y; Zhao Y; Guo R; Xiong L; Ji Z; Li Y; Li Q; Qin C
    Front Genet; 2023; 14():1138137. PubMed ID: 36999060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.